Tag: Boehringer ingelheim

The brand name medication Twynsta was discontinued in the U.S. not for safety or effectiveness reasons, but as a manufacturer's business decision. This means that while the brand is no longer on pharmacy shelves, the combined generic version of its active ingredients, telmisartan and amlodipine, remains widely available.

The global pharmaceutical market was valued at approximately $1.65 trillion in 2024 [1.8.1, 1.8.3]. While dominated by publicly traded giants, the answer to 'What is the largest privately owned pharmaceutical company?' is the German-based Boehringer Ingelheim, with 2024 revenues of €26.8 billion [1.3.1, 1.3.5].